Rs 10.3 billion for Cadila. The company, which has manufacturing and marketing tie-ups with global firms like Abbott Laboratories, Bayer AG, Hospira Inc and unlisted Swiss drugmaker Nycomed, reported a 43.25 per cent rise in January-March net sales, it...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Cadila Healthcare Q4 net up 50.4 pct
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account